These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12866308

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Night-time hypoglycemia in patients with type 2 diabetes].
    Stiefelhagen P.
    MMW Fortschr Med; 2009 Jun 25; 151(26-29):40-1. PubMed ID: 19739548
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [New insulin with uniform action. Hazards of blood sugar variations minimized].
    MMW Fortschr Med; 2003 Oct 02; 145(40):55. PubMed ID: 14603609
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M, Zhou J, Bo YQ, Lu W, Jia WP, Xiang KS.
    Zhonghua Yi Xue Za Zhi; 2008 Jun 24; 88(24):1679-82. PubMed ID: 19024537
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL.
    Curr Diab Rep; 2005 Oct 24; 5(5):326-8. PubMed ID: 16188165
    [No Abstract] [Full Text] [Related]

  • 11. Insulin detemir--a new basal insulin analog.
    Goldman-Levine JD, Lee KW.
    Ann Pharmacother; 2005 Mar 24; 39(3):502-7. PubMed ID: 15657117
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Insulin aspart: a review.
    Owens D, Vora J.
    Expert Opin Drug Metab Toxicol; 2006 Oct 24; 2(5):793-804. PubMed ID: 17014395
    [Abstract] [Full Text] [Related]

  • 15. Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region.
    Ayad NM, Fattah WA, Bakry H.
    Saudi Med J; 2008 Jun 24; 29(6):919-20. PubMed ID: 18521482
    [No Abstract] [Full Text] [Related]

  • 16. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group.
    Diabetes Obes Metab; 2008 Mar 24; 10(3):212-22. PubMed ID: 18269636
    [Abstract] [Full Text] [Related]

  • 17. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y, Guo XH, Vaz JA, PRESENT Study Group.
    Diabetes Obes Metab; 2009 Jan 24; 11(1):33-40. PubMed ID: 18494806
    [Abstract] [Full Text] [Related]

  • 18. Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
    Garza H.
    Consult Pharm; 2009 Jun 24; 24 Suppl B():18-24. PubMed ID: 19555132
    [Abstract] [Full Text] [Related]

  • 19. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 24; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 20. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
    Dailey G, Strange P.
    Am J Manag Care; 2008 Jan 24; 14(1):25-30. PubMed ID: 18197742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.